Monografie
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
- Sprache
-
Englisch
- Identifier
-
1177382385
Thema
T cells; Melanoma; Memory; Mice; Immunotherapy; adoptive transfer; memory T cells; malignant melanoma; ret transgenic melanoma mouse model; Hochschulschrift
Beteiligte Personen und Organisationen
- DOI
-
10.11588/heidok.00015486
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Objekttyp
- Monografie
Beteiligte
- Stemke, Anastasia
- Umansky, Viktor
Ähnliche Objekte (12)
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Dormant tumor cells in ret transgenic mouse melanoma model and their interaction with memory T cells
Extracellular adenosine metabolism in melanoma and pancreatic cancer
Improved dendritic cell vaccination for combined melanoma immune therapy
STAT3 – the switch of melanoma-associated NRAS mutations
Modelling melanoma control by immunotherapy and tissue-resident memory T cells using CRISPR/Cas9-based approaches
Role of RAGE in melanoma development, growth, and progression
Immunosuppression in malignant melanoma induced by tumor-derived extracellular vesicles
Partial reprogramming - a model for melanoma targeted therapy resistance
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
Innate immune cell crosstalk induces melanoma cell senescence
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Dormant tumor cells in ret transgenic mouse melanoma model and their interaction with memory T cells
Extracellular adenosine metabolism in melanoma and pancreatic cancer
Improved dendritic cell vaccination for combined melanoma immune therapy
STAT3 – the switch of melanoma-associated NRAS mutations
Modelling melanoma control by immunotherapy and tissue-resident memory T cells using CRISPR/Cas9-based approaches
Role of RAGE in melanoma development, growth, and progression
Immunosuppression in malignant melanoma induced by tumor-derived extracellular vesicles
Partial reprogramming - a model for melanoma targeted therapy resistance
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
Innate immune cell crosstalk induces melanoma cell senescence
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Dormant tumor cells in ret transgenic mouse melanoma model and their interaction with memory T cells
Extracellular adenosine metabolism in melanoma and pancreatic cancer
Improved dendritic cell vaccination for combined melanoma immune therapy
STAT3 – the switch of melanoma-associated NRAS mutations
Modelling melanoma control by immunotherapy and tissue-resident memory T cells using CRISPR/Cas9-based approaches
Role of RAGE in melanoma development, growth, and progression
Immunosuppression in malignant melanoma induced by tumor-derived extracellular vesicles
Partial reprogramming - a model for melanoma targeted therapy resistance
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma